What is Scienjoy's operating income?

Scienjoy's total operating income in 2025 was -$11.28 million, based on the following breakdown: Total Gross Profit: $32.48 million Total Operating Expenses: $109.22 million

Scienjoy (SJ) Financials

$0.86 -0.06 (-6.52%)

Closing price 04:00 PM Eastern

Extended Trading

$0.88 +0.02 (+1.74%)

As of 04:10 PM Eastern

Compare

Annual Income Statements for Scienjoy

This table shows Scienjoy's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	16	22	27	27	28	-4.34	5.44	-84
Consolidated Net Income / (Loss)	16	22	27	27	56	-9.26	9.09	-169
Net Income / (Loss) Continuing Operations	16	22	27	27	28	-4.93	3.66	-85
Total Pre-Tax Income	16	22	28	28	31	-3.73	5.38	-97
Total Operating Income	16	22	28	26	22	3.21	5.58	-11
Total Gross Profit	22	28	40	48	41	27	34	32
Total Revenue	108	131	187	262	283	206	187	178
Operating Revenue	108	131	187	262	283	206	187	178
Total Cost of Revenue	87	104	146	214	243	182	157	163
Operating Cost of Revenue	86	103	147	214	242	179	153	145
Other Cost of Revenue	0.99	0.12	-1.27	-0.25	0.40	2.52	4.19	18
Total Operating Expenses	4.69	5.35	14	27	17	23	25	109
Selling, General & Admin Expense	2.37	1.72	5.21	10	8.84	11	10	13
Marketing Expense	0.73	0.55	1.56	0.75	0.31	0.19	0.97	0.91
Research & Development Expense	1.59	3.09	4.89	11	9.79	11	12	12
Impairment Charge	-	-	-	0.00	0.00	1.66	1.43	84
Total Other Income / (Expense), net	0.21	0.00	0.44	6.78	7.20	-5.28	1.23	-1.64
Interest & Investment Income	0.21	-	0.46	0.15	4.05	-4.03	-0.35	1.49
Other Income / (Expense), net	0.00	0.00	-0.01	6.63	3.14	-1.26	1.58	-3.13
Income Tax Expense	0.67	0.95	1.14	0.88	2.62	1.19	1.73	-11
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	0.00	0.00	0.27	-0.59	-1.78	-1.13
Basic Earnings per Share	$5.50	$7.73	$7.56	$5.51	$0.71	($0.11)	$0.13	($0.29)
Weighted Average Basic Shares Outstanding	19.40M	19.40M	23.29M	30.84M	39.26M	40.65M	41.37M	41.78M
Diluted Earnings per Share	$5.34	$7.50	$6.56	$5.51	$0.71	($0.11)	$0.13	($0.29)
Weighted Average Diluted Shares Outstanding	20.00M	20.00M	26.83M	30.84M	39.26M	40.65M	41.56M	41.78M
Weighted Average Basic & Diluted Shares Outstanding	-	2.28M	27.04M	30.84M	39.61M	41.04M	41.85M	42.46M

No quarterly income statements for Scienjoy are available.

This table details how cash moves in and out of Scienjoy's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-9.34	10	13	2.54	-9.52	4.25	6.45	7.88
Net Cash From Operating Activities	16	33	24	18	8.34	14	9.41	10
Net Cash From Continuing Operating Activities	16	33	24	18	8.34	14	9.41	10
Net Income / (Loss) Continuing Operations	16	22	27	27	28	-4.93	3.66	-85
Consolidated Net Income / (Loss)	16	22	27	27	28	-4.93	3.66	-85
Depreciation Expense	0.17	0.09	0.09	0.12	0.17	0.17	0.15	0.17
Amortization Expense	0.00	0.00	0.27	0.64	1.93	1.97	1.96	1.87
Non-Cash Adjustments To Reconcile Net Income	0.99	0.12	-1.27	-1.41	-3.38	11	5.93	105
Changes in Operating Assets and Liabilities, net	-1.09	11	-2.26	-7.78	-19	6.47	-2.28	-12
Net Cash From Investing Activities	-0.08	-0.78	-6.30	-18	-16	-9.46	-2.75	-0.87
Net Cash From Continuing Investing Activities	-0.08	-0.78	-6.30	-18	-16	-9.46	-2.75	-0.87
Purchase of Property, Plant & Equipment	-0.08	-0.07	-0.17	-0.22	-0.31	-0.07	-0.14	-0.12
Acquisitions	0.00	0.00	-7.69	0.00	-	-0.50	0.00	-0.18
Purchase of Investments	0.00	-0.72	0.00	-18	-18	-9.00	-2.67	-22
Divestitures	0.00	0.00	1.56	0.00	1.41	0.03	0.00	0.26
Sale and/or Maturity of Investments	-	-	-	-	-	0.07	0.06	21
Net Cash From Financing Activities	-25	-22	-3.59	2.40	-1.66	-0.74	-0.02	-0.01
Net Cash From Continuing Financing Activities	-25	-22	-3.59	2.40	-1.66	-0.74	-0.02	-0.01
Repayment of Debt	8.62	-6.53	-7.55	0.00	0.00	-1.30	0.05	-0.01
Repurchase of Common Equity	0.00	-0.19	-1.06	0.00	-2.39	-0.39	-0.10	0.00
Issuance of Debt	-	-	0.00	0.00	0.72	0.70	0.00	0.00
Issuance of Common Equity	-	0.00	0.00	2.40	0.00	0.25	0.03	0.00
Cash Income Taxes Paid	0.51	1.00	-	1.49	-1.32	-1.89	-2.17	-1.18

No quarterly cash flow statements for Scienjoy are available.

This table presents Scienjoy's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	0.37	40	125	171	218	204	193	102
Total Current Assets	0.05	39	72	102	94	81	75	55
Cash & Equivalents	0.05	20	35	38	25	29	35	44
Short-Term Investments	-	-	0.00	6.09	5.88	4.44	5.16	1.22
Accounts Receivable	-	17	35	33	46	37	31	6.19
Prepaid Expenses	0.00	1.66	2.12	26	17	11	3.89	3.38
Plant, Property, & Equipment, net	0.00	0.11	0.21	0.26	0.40	0.31	0.27	0.32
Total Noncurrent Assets	0.31	1.40	53	68	121	122	118	46
Long-Term Investments	-	0.72	0.77	16	34	36	35	39
Goodwill	-	0.00	14	14	25	26	25	0.00
Intangible Assets	-	0.03	37	37	61	58	56	0.00
Noncurrent Deferred & Refundable Income Taxes	-	0.07	0.87	0.68	0.63	1.04	1.03	5.33
Other Noncurrent Operating Assets	0.31	0.58	0.21	0.18	2.92	1.81	0.79	2.35
Total Liabilities & Shareholders' Equity	0.37	40	125	171	218	204	193	102
Total Liabilities	0.40	15	54	44	49	42	30	17
Total Current Liabilities	0.40	15	43	35	38	33	22	15
Accounts Payable	0.00	6.10	12	16	19	10	4.93	2.38
Accrued Expenses	-	-	-	-	-	3.89	0.94	1.39
Current Deferred Revenue	-	5.78	7.62	10	14	14	11	7.22
Current Deferred & Payable Income Tax Liabilities	-	1.21	1.32	1.30	1.96	1.83	1.55	1.56
Current Employee Benefit Liabilities	-	1.25	2.79	3.85	1.80	2.08	3.06	2.17
Other Current Liabilities	0.01	0.00	4.55	3.29	0.90	1.12	0.56	0.52
Total Noncurrent Liabilities	0.00	0.00	12	9.22	8.88	9.10	8.10	1.49
Capital Lease Obligations	-	-	-	0.00	-	0.68	0.10	1.49
Noncurrent Deferred & Payable Income Tax Liabilities	-	0.00	9.19	9.22	8.88	8.43	8.00	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-0.04	25	71	127	169	162	162	85
Total Preferred & Common Equity	-0.04	25	71	127	168	162	164	88
Total Common Equity	-0.04	25	71	127	163	162	164	88
Common Stock	0.03	1.39	-15	24	61	63	64	68
Retained Earnings	-0.06	22	50	75	96	89	91	13
Treasury Stock	-	-	-	0.00	-2.39	-2.71	-2.73	-2.85
Accumulated Other Comprehensive Income / (Loss)	-	0.00	2.28	2.69	2.62	2.53	2.32	1.84
Other Equity Adjustments	-	1.73	34	25	5.68	11	9.80	7.85
Noncontrolling Interest	-	-	-	0.00	0.27	-0.12	-1.89	-3.14

No quarterly balance sheets for Scienjoy are available.

This table displays calculated financial ratios and metrics derived from Scienjoy's official financial filings.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	0.00	7,457,500.00	27,037,302.00	30,844,641.00	39,609,726.00	41,038,937.00	41,038,937.00	41,038,937.00
DEI Adjusted Shares Outstanding	0.00	7,457,500.00	27,037,302.00	30,844,641.00	39,609,726.00	41,038,937.00	41,038,937.00	41,038,937.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	2.89	1.00	0.86	0.71	-0.11	0.13	-2.05
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	21.43%	42.54%	39.95%	8.11%	-27.14%	-9.47%	-4.94%
EBITDA Growth	0.00%	39.76%	24.46%	18.89%	-19.38%	-84.77%	125.75%	-233.54%
EBIT Growth	0.00%	40.66%	23.42%	17.68%	-23.92%	-92.13%	265.72%	-301.40%
NOPAT Growth	0.00%	40.57%	23.74%	-5.44%	-21.17%	-88.69%	68.52%	-308.37%
Net Income Growth	0.00%	38.55%	25.83%	-1.50%	111.16%	-116.44%	198.16%	-1,959.10%
EPS Growth	0.00%	40.45%	-12.53%	-16.01%	-87.05%	-115.00%	221.59%	-320.91%
Operating Cash Flow Growth	0.00%	110.45%	-27.25%	-23.66%	-54.28%	73.35%	-34.91%	7.11%
Free Cash Flow Firm Growth	0.00%	0.00%	-206.11%	143.40%	-332.77%	176.65%	-28.01%	694.70%
Invested Capital Growth	0.00%	1,696.33%	814.76%	35.64%	55.83%	-10.75%	-6.35%	-97.34%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	20.05%	21.21%	21.55%	18.24%	14.50%	13.16%	18.00%	18.30%
EBITDA Margin	14.95%	17.21%	15.02%	12.76%	9.52%	1.99%	4.96%	-6.97%
Operating Margin	14.79%	17.13%	14.84%	9.94%	7.67%	1.56%	2.99%	-6.35%
EBIT Margin	14.79%	17.13%	14.83%	12.47%	8.78%	0.95%	3.83%	-8.12%
Profit (Net Income) Margin	14.37%	16.39%	14.47%	10.18%	19.89%	-4.49%	4.87%	-95.21%
Tax Burden Percent	95.85%	95.77%	95.97%	96.81%	182.17%	248.20%	168.96%	175.03%
Interest Burden Percent	101.34%	99.90%	101.64%	84.34%	124.40%	-190.71%	75.20%	670.09%
Effective Tax Rate	4.15%	4.23%	4.03%	3.19%	8.47%	0.00%	32.07%	0.00%
Return on Invested Capital (ROIC)	5,087.13%	754.17%	97.08%	43.22%	23.14%	2.27%	4.19%	-17.59%
ROIC Less NNEP Spread (ROIC-NNEP)	5,148.64%	754.40%	95.01%	39.60%	-35.78%	19.66%	-3.20%	187.10%
Return on Net Nonoperating Assets (RNNOA)	-48,560.72%	-582.12%	-40.50%	-16.23%	14.98%	-7.88%	1.42%	-119.15%
Return on Equity (ROE)	-43,473.59%	172.05%	56.58%	26.99%	38.12%	-5.61%	5.61%	-136.73%
Cash Return on Invested Capital (CROIC)	0.00%	575.26%	-63.50%	12.97%	-20.51%	13.63%	10.75%	172.04%
Operating Return on Assets (OROA)	4,357.31%	110.92%	33.65%	22.09%	12.79%	0.93%	3.61%	-9.80%
Return on Assets (ROA)	4,232.33%	106.12%	32.82%	18.04%	28.99%	-4.39%	4.59%	-114.95%
Return on Common Equity (ROCE)	-43,473.59%	172.05%	56.58%	26.99%	37.45%	-5.52%	5.64%	-139.51%
Return on Equity Simple (ROE_SIMPLE)	0.00%	85.90%	38.32%	21.00%	33.48%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	15	22	27	25	20	2.25	3.79	-7.90
NOPAT Margin	14.17%	16.41%	14.24%	9.62%	7.02%	1.09%	2.03%	-4.45%
Net Nonoperating Expense Percent (NNEP)	-61.50%	-0.23%	2.07%	3.62%	58.92%	-17.38%	7.39%	-204.68%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	11.70%	1.38%	2.33%	-9.14%
Cost of Revenue to Revenue	80.87%	78.88%	77.77%	81.67%	85.64%	88.06%	84.24%	91.96%
SG&A Expenses to Revenue	2.19%	1.31%	2.78%	3.91%	3.12%	5.16%	5.62%	7.17%
R&D to Revenue	1.47%	2.35%	2.61%	4.20%	3.46%	5.13%	6.64%	6.72%
Operating Expenses to Revenue	4.34%	4.08%	7.38%	10.40%	6.02%	11.19%	13.54%	61.51%
Earnings before Interest and Taxes (EBIT)	16	22	28	33	25	1.96	7.16	-14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	16	23	28	33	27	4.11	9.27	-12
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	1.21	0.37	0.00	0.26	0.32
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	2.03	0.78	0.00	0.51	0.32
Price to Revenue (P/Rev)	0.46	0.00	0.00	0.59	0.21	0.00	0.23	0.16
Price to Earnings (P/E)	3.22	0.00	0.00	5.76	2.17	0.00	7.85	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	31.07%	0.00%	0.00%	17.37%	46.13%	0.00%	12.74%	0.00%
Enterprise Value to Invested Capital (EV/IC)	167.05	0.00	0.00	1.40	0.02	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.47	0.00	0.00	0.36	0.01	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	3.11	0.00	0.00	2.80	0.08	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	3.15	0.00	0.00	2.87	0.08	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	3.28	0.00	0.00	3.72	0.10	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	3.22	0.00	0.00	5.13	0.25	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	12.38	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	-10.91	0.03	0.20	0.00	0.01	0.00	0.00	0.02
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02
Financial Leverage	-9.43	-0.77	-0.43	-0.41	-0.42	-0.40	-0.44	-0.64
Leverage Ratio	-10.27	1.62	1.72	1.50	1.32	1.28	1.22	1.19
Compound Leverage Factor	-10.41	1.62	1.75	1.26	1.64	-2.43	0.92	7.97
Debt to Total Capital	110.09%	3.07%	16.71%	0.00%	0.80%	0.42%	0.06%	1.72%
Short-Term Debt to Total Capital	110.09%	3.07%	16.71%	0.00%	0.80%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.42%	0.06%	1.72%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	2.89%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.16%	-0.07%	-1.16%	-3.64%
Common Equity to Total Capital	-10.09%	96.93%	83.29%	100.00%	96.15%	99.66%	101.10%	101.91%
Debt to EBITDA	0.02	0.04	0.50	0.00	0.05	0.16	0.01	-0.12
Net Debt to EBITDA	0.02	-0.87	-0.75	0.00	-2.37	-16.70	-8.08	6.67
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.16	0.01	-0.12
Debt to NOPAT	0.03	0.04	0.53	0.00	0.07	0.30	0.03	-0.19
Net Debt to NOPAT	0.02	-0.91	-0.79	0.00	-3.21	-30.48	-19.77	10.45
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.30	0.03	-0.19
Altman Z-Score	511.49	0.00	0.00	5.35	3.34	0.00	2.93	2.95
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	1.76%	1.54%	-0.62%	-2.03%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	0.13	2.56	1.68	2.95	2.44	2.46	3.39	3.60
Quick Ratio	0.13	2.45	1.63	2.20	2.01	2.13	3.21	3.37
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	16	-17	7.57	-18	14	9.72	77
Operating Cash Flow to CapEx	19,400.71%	50,084.73%	14,313.13%	8,373.02%	2,673.06%	20,830.30%	6,955.08%	8,424.88%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	294.60	6.47	2.27	1.77	1.46	0.98	0.94	1.21
Accounts Receivable Turnover	0.00	0.00	7.14	7.75	7.22	4.99	5.51	9.56
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	1,191.38	1,111.77	859.18	584.97	643.77	599.54
Accounts Payable Turnover	0.00	0.00	15.89	15.16	13.95	12.49	20.65	44.63
Days Sales Outstanding (DSO)	0.00	0.00	51.11	47.12	50.56	73.17	66.22	38.20
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	22.97	24.08	26.17	29.21	17.68	8.18
Cash Conversion Cycle (CCC)	0.00	0.00	28.14	23.05	24.38	43.95	48.55	30.02
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	0.30	5.41	50	67	105	93	87	2.33
Invested Capital Turnover	358.89	45.96	6.82	4.49	3.30	2.08	2.07	3.95
Increase / (Decrease) in Invested Capital	0.00	5.11	44	18	37	-11	-5.93	-85
Enterprise Value (EV)	50	0.00	0.00	94	2.06	0.00	-34	-57
Market Capitalization	50	0.00	0.00	154	61	0.00	43	29
Book Value per Share	$0.00	$3.36	$9.48	$4.70	$5.30	$3.99	$4.00	$2.11
Tangible Book Value per Share	$0.00	$3.36	$2.64	$2.79	$2.51	$1.93	$2.04	$2.11
Total Capital	0.35	26	85	127	170	163	162	86
Total Debt	0.39	0.79	14	0.00	1.35	0.68	0.10	1.49
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.68	0.10	1.49
Net Debt	0.34	-20	-21	-60	-64	-69	-75	-83
Capital Expenditures (CapEx)	0.08	0.07	0.17	0.22	0.31	0.07	0.14	0.12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.01	4.63	8.72	24	26	15	13	-5.66
Debt-free Net Working Capital (DFNWC)	0.04	24	43	68	57	48	53	40
Net Working Capital (NWC)	-0.35	24	29	68	56	48	53	40
Net Nonoperating Expense (NNE)	-0.21	0.02	-0.42	-1.47	-36	12	-5.30	161
Net Nonoperating Obligations (NNO)	0.34	-20	-21	-60	-64	-69	-75	-83
Total Depreciation and Amortization (D&A)	0.17	0.10	0.35	0.76	2.10	2.15	2.11	2.04
Debt-free, Cash-free Net Working Capital to Revenue	-0.01%	3.52%	4.66%	9.08%	9.05%	7.23%	6.87%	-3.19%
Debt-free Net Working Capital to Revenue	0.04%	18.54%	23.13%	25.84%	20.10%	23.41%	28.16%	22.28%
Net Working Capital to Revenue	-0.32%	17.94%	15.55%	25.84%	19.62%	23.41%	28.16%	22.28%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.35)	$0.00	$0.87	$0.71	($0.11)	$0.02	($0.29)
Adjusted Weighted Average Basic Shares Outstanding	0.00	7.46M	23.29M	30.84M	39.26M	40.65M	41.37M	41.78M
Adjusted Diluted Earnings per Share	$0.00	($0.35)	$1.01	$0.87	$0.71	($0.11)	$0.02	($0.29)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	7.46M	26.83M	30.84M	39.26M	40.65M	41.56M	41.78M
Adjusted Basic & Diluted Earnings per Share	$0.00	($0.35)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	2.28M	27.04M	30.84M	39.61M	41.04M	41.85M	42.46M
Normalized Net Operating Profit after Tax (NOPAT)	15	22	27	25	20	3.41	4.76	51
Normalized NOPAT Margin	14.17%	16.41%	14.24%	9.62%	7.02%	1.65%	2.55%	28.53%
Pre Tax Income Margin	14.99%	17.12%	15.08%	10.52%	10.92%	-1.81%	2.88%	-54.39%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	214.07%	69.76%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	214.07%	70.64%	3.93%	0.00%	4.24%	-4.16%	1.11%	0.00%

No quarterly metrics and ratios for Scienjoy are available.

Financials Breakdown Chart

Scienjoy Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Scienjoy's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Scienjoy's net income appears to be on an upward trend, with a most recent value of -$169.04 million in 2025, falling from $15.54 million in 2018. The previous period was $9.09 million in 2024. View Scienjoy's forecast to see where analysts expect Scienjoy to go next.

Scienjoy's total operating income in 2025 was -$11.28 million, based on the following breakdown:

Total Gross Profit: $32.48 million
Total Operating Expenses: $109.22 million

Over the last 7 years, Scienjoy's total revenue changed from $108.14 million in 2018 to $177.55 million in 2025, a change of 64.2%.

Scienjoy's total liabilities were at $16.73 million at the end of 2025, a 44.5% decrease from 2024, and a 4,052.7% increase since 2018.

In the past 7 years, Scienjoy's cash and equivalents has ranged from $52.94 thousand in 2018 to $43.99 million in 2025, and is currently $43.99 million as of their latest financial filing in 2025.

Over the last 7 years, Scienjoy's book value per share changed from 0.00 in 2018 to 2.11 in 2025, a change of -117,127.8%.

Related Companies

Financial statements for NASDAQ:SJ last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Scienjoy (SJ) Financials

Financials Breakdown Chart

Scienjoy Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Scienjoy (SJ) Financials

Annual Income Statements for Scienjoy

Quarterly Income Statements for Scienjoy

Annual Cash Flow Statements for Scienjoy

Quarterly Cash Flow Statements for Scienjoy

Annual Balance Sheets for Scienjoy

Quarterly Balance Sheets for Scienjoy

Annual Metrics And Ratios for Scienjoy

Quarterly Metrics And Ratios for Scienjoy

Financials Breakdown Chart

Scienjoy Financials - Frequently Asked Questions

When does Scienjoy's fiscal year end?

How has Scienjoy's net income changed over the last 7 years?

What is Scienjoy's operating income?

How has Scienjoy's revenue changed over the last 7 years?

How much debt does Scienjoy have?

How much cash does Scienjoy have?

How has Scienjoy's book value per share changed over the last 7 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools